Presentations and Reports

Quarterly Results and Presentations
IN THIS SECTION

Covington Day

Nov 07, 2018

Third Quarter 2018 Results

Nov 01, 2018

For Takeda's quarterly results and presentations, please refer to https://www.takeda.com/investors/reports/quarterly-announcements/

Date
Title
Press
Presentation
Webcast
Transcript
  • Nov 19, 2018
    Japan roadshow handout
    PDF, 1.9MB, opens in a new window
  • Nov 07, 2018
    Covington Day
    pdf, 7.4MB, opens in a new window
    Opens in a new window
  • Nov 01, 2018
    Third Quarter 2018 Results
    pdf, 850KB, opens in a new window
    pdf, 481KB, opens in a new window
    Opens in a new window
  • Aug 27, 2018
    Shire Corporate Presentation
    pdf, 1.6MB, opens in a new window
  • Jul 31, 2018
    Second Quarter 2018 Results
    pdf, 1.5MB, opens in a new window
    pdf, 847KB, opens in a new window
    Opens in a new window
  • Apr 26, 2018
    First Quarter 2018 Results
    pdf, 690KB, opens in a new window
    pdf, 1.2MB, opens in a new window
    Opens in a new window
  • Mar 07, 2018
    Prucalopride (SHP555) Update for Global Investors
    Press Releases
    pdf, 216KB, opens in a new window
    Opens in a new window
  • Feb 14, 2018
    Full Year 2017 Results
    pdf, 1.4MB, opens in a new window
    pdf, 1.8MB, opens in a new window
    Opens in a new window
  • Jan 08, 2018
    36th Annual J.P. Morgan Healthcare Conference Presentation
    pdf, 1.6MB, opens in a new window
    Opens in a new window
  • Jan 08, 2018
    36th Annual J.P. Morgan Healthcare Conference Q&A session
    Opens in a new window

Copyright Takeda Pharmaceutical Company Limited. All rights reserved.

By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.

By following this link you will be leaving the global Shire.com website for another Shire website. Please note that this website may not be appropriate for all audiences.

RETURN CONTINUE
Powered by Sitecore